Tag: cyclophosphamide
Cyclophosphamide: Trade name Cytoxan, a chemotherapy drug. Cyclophosphamide is an alkylating agent frequently used in combination with anthracyclines (Adriamycin, epirubicin) and/or taxanes (Taxol, Taxotere).
News
07/09/12
Orange flavonoid hesperidin could reduce effectiveness of cyclophosphamide 02/15/12
Grapes and other foods might help protect against Adriamycin-induced heart damage 12/07/11
Modern chemotherapy reduces breast cancer death by about a third compared to no chemotherapy 10/09/11
Low white blood cell count as a result of chemotherapy indicates the treatment is working 10/06/11
Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer 10/03/11
Simultaneous chemotherapy plus radiation treatment reduces breast cancer recurrence 02/04/11
Triple negative breast cancer in BRCA1 mutation carriers and noncarriers has similar prognosis 12/10/10
Adding the bisphosphonate zoledronic acid to chemotherapy does not improve outcome markers
Foods
Studies
Rutin, a Quercetin Glycoside, Restores Chemosensitivity in Human Breast Cancer Cells Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study Weight change during chemotherapy in breast cancer patients: a meta-analysis Ovarian protection in cyclophosphamide-treated mice by fennel Time-of-Day Dictates Transcriptional Inflammatory Responses to Cytotoxic Chemotherapy Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases Serum IL-6 level as a predictor of response to neo-Adjuvant chemotherapy in patients of breast carcinoma Protective Effects of Essential Oils as Natural Antioxidants against Hepatotoxicity Induced by Cyclophosphamide in Mice Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study Cardioprotective Effect of Selenium Against Cyclophosphamide-Induced Cardiotoxicity in Rats Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase-Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer A Systematic Review and Network Meta-analysis Late effects of adjuvant chemotherapy for breast cancer on fine motor function Renoprotective effect of Mangifera indica polysaccharides and silymarin against cyclophosphamide toxicity in rats A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9 The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009 A mixture of honey bee products ameliorates the genotoxic side effects of cyclophosphamide Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance) Combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil causes trabecular bone loss, bone marrow cell depletion and marrow adiposity in female rats Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario Modulation of Murine Breast Tumor Vascularity, Hypoxia and Chemotherapeutic Response by Exercise Rutin ameliorates cyclophosphamide induced oxidative stress and inflammation in Wistar rats: Role of NFκB/MAPK pathway Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy - 25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer Investigating effects of hydroalcoholic extract of saffron on sex hormones in female rats undergoing chemotherapy with cyclophosphamide Modulation of cyclophosphamide-induced early lung injury by allicin Citrus Limonin Lacks the Antichemotherapeutic Effect in Human Models of Breast Cancer Hesperidin Inhibits Cyclophosphamide-Induced Tumor Growth Delay in Mice Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis Surgery for widely disseminated breast cancer: prolonged control by excision of metastases In vivo antigenotoxic activity of watercress juice (Nasturtium officinale) against induced DNA damage Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy Avocado fruit (Persea americana Mill) exhibits chemo-protective potentiality against cyclophosphamide induced genotoxicity in human lymphocyte culture Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients in northeast china Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials Twenty-five year results of the national cancer institute randomized breast conservation trial Does Surgery for Breast Cancer Induce Angiogenesis and Thus Promote Metastasis? Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer Adjuvant Trastuzumab in HER2-Positive Breast Cancer Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial Response to influenza virus vaccination during chemotherapy in patients with breast cancer Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer Hematologic toxicity with adjuvant docetaxel and cyclophosphamide in early breast cancer Hepatotoxicity in breast cancer patients post-chemotherapy with docetaxel, doxorubucin, and cyclophosphamide Differential response from neoadjuvant chemotherapy across breast cancer subtypes Weight change during adjuvant chemotherapy regimens for breast cancer Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer Severe dietary restriction enhances cancer treatment: Protecting normal cells and sensitizing malignant cells to chemotherapy by fasting Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation Cyclophosphamide Dose Intensification May Circumvent Anthracycline Resistance of p53 Mutant Breast Cancers Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment Antiproliferative Effects of Honey and of Its Polyphenols: A Review Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer Antigenotoxic effect of apigenin against anti-cancerous drugs Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice Influence of orange juice over the genotoxicity induced by alkylating agents: an in vivo analysis
TOP